Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Labcorp says it could ramp up mpox testing capacity
06:22am, Monday, 26'th Aug 2024
Diagnostics firm Labcorp said it is processing approximately 500 mpox tests a month but have the capacity to process approximately 25,000 per month.
Should You Hold Labcorp (LH) Stock in Your Portfolio Now?
09:55am, Thursday, 22'nd Aug 2024
Labcorp's (LH) slew of partnerships and acquisitions and robust efforts in high-growth areas bode well.
Labcorp (LH) Gains From New Collaborations Amid FX Issues
01:47pm, Wednesday, 14'th Aug 2024
Labcorp's (LH) Biopharma Laboratory Services business is benefiting from collaborations with leading pharmaceutical and biotechnology companies.
Labcorp Finalizes Acquisition of Select Assets of Invitae
07:00am, Monday, 05'th Aug 2024
Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases BURLINGTON, N.C. , Aug. 5, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and c
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
11:31am, Friday, 02'nd Aug 2024
Labcorp Holdings Inc LH reported better-than-expected second-quarter financial results and raised its FY24 revenue guidance above estimates on Thursday.
Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx
08:30am, Friday, 02'nd Aug 2024
PGDx elio™ plasma focus Dx is the industry's first and only kitted, pan-solid tumor liquid biopsy test that enables tumor mutation profiling – all from a simple blood draw BURLINGTON, N.C., Aug.
Labcorp (LH) Q2 Earnings Surpass Estimates (revised)
04:05pm, Thursday, 01'st Aug 2024
Labcorp (LH) beats on earnings and revenues in the second quarter, entering the second half of 2024 with robust momentum.
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
01:31pm, Thursday, 01'st Aug 2024
Thursday, Laboratory Corp A reported second-quarter 2024 adjusted EPS of $3.94, up from $3.42 a year ago, beating the consensus of $3.78.
Labcorp (LH) Q2 Earnings Surpass Estimates, Margins Increase
10:50am, Thursday, 01'st Aug 2024
Labcorp (LH) beats on earnings and revenues in the second quarter, entering the second half of 2024 with robust momentum.
Compared to Estimates, Labcorp (LH) Q2 Earnings: A Look at Key Metrics
10:36am, Thursday, 01'st Aug 2024
The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
Labcorp (LH) Beats Q2 Earnings and Revenue Estimates
09:11am, Thursday, 01'st Aug 2024
Labcorp (LH) came out with quarterly earnings of $3.94 per share, beating the Zacks Consensus Estimate of $3.78 per share. This compares to earnings of $3.42 per share a year ago.
Labcorp beats Q2 profit and revenue estimates on demand for health tests
07:29am, Thursday, 01'st Aug 2024
Labcorp beat Wall Street expectations for second-quarter profit and revenue on Thursday on strong demand for its diagnostic tests, and raised its sales growth forecast for the year.
Labcorp Announces 2024 Second Quarter Results
06:57am, Thursday, 01'st Aug 2024
Updates Full-Year Guidance Results from Continuing Operations for second quarter 2024 versus last year: Revenue: $3.22 billion versus $3.03 billion Diluted EPS: $2.43 versus $1.74 Adjusted EPS: $3.94
What's in Store for These 4 MedTech Stocks in Q2 Earnings?
01:01pm, Wednesday, 31'st Jul 2024
Here is a sneak peek into how four MedTech companies, LH, BIO, TFX and BRKR, are expected to fare in their second-quarter results, slated to be released tomorrow.
Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities
07:00am, Tuesday, 30'th Jul 2024
BURLINGTON, N.C., and FREMONT, Calif.
